Form 8-K - Current report:
SEC Accession No. 0001193125-26-325031
Filing Date
2026-07-30
Accepted
2026-07-30 08:32:49
Documents
11
Period of Report
2026-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K iron-20260730.htm   iXBRL 8-K 46251
2 EX-99.1 iron-ex99_1.htm EX-99.1 164556
3 GRAPHIC img57926557_0.jpg GRAPHIC 896859
  Complete submission text file 0001193125-26-325031.txt   1539746

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT iron-20260730.xsd EX-101.SCH 26027
14 EXTRACTED XBRL INSTANCE DOCUMENT iron-20260730_htm.xml XML 4922
Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

EIN.: 851612845 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 261220366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)